Home » Newsletters » BioWorld Science

BioWorld Science

July 15, 2005

View Archived Issues

Glatiramer acetate reduces relapses more than beta interferons in multiple sclerosis

AZD-0530 inhibits osteoclast-mediated bone resorption in healthy volunteers

Lithium shows promise as anabolic bone therapy

Therapeutic benefits of melatonin in hemodialysis patients

SGN-35 shows potency in CD30+ malignancies in vitro; clinical trials to start shortly

20(S)-Protopanaxatriol exerts antitumor effects in lung cancer cells

CT-3: a novel synthetic cannabinoid for pain / News in Context

Novel tri-action somatostatin-dopamine agonists studied for control of GH secretion

FR-193262: a novel prostacyclin mimetic with oral bioavailability and antiaggregative effect

JYL-1421 is a potent TRPV1 antagonist in vitro and in vivo

PKCzeta --a novel target for asthma therapy

CJ-730: a novel matriptase inhibitor with antimetastatic properties

Marc Pharmaceuticals to investigate betulinol derivative for prostate cancer

Velcura receives SBIR for development of drugs for bone disorders

SR Pharma advances acquisition of Atugen

United Biomedical awarded NIH contract for therapeutic AIDS vaccine

Xenomics and Spallanzani sign definitive agreement for SpaXen joint venture

Corixa stockholder approval of merger with GlaxoSmithKline

Allergan to evaluate Pharmacopeia compounds in models of ocular disease

SBIR grant supports development AV-101 for neuropathic pain

Xsira receives IND clearance for phase II study of adenosine for pain

MEND-CABG study of MC-1 completes enrollment

Hemosol selects IGIV as first therapeutic protein product for development

New agents for gastrointestinal disorders described in recent patent literature

New antibacterial transcription inhibitors emerge from French R&D